These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3828830)
1. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system. Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830 [TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines. Campbell A; Baldessarini RJ; Ram VJ; Neumeyer JL Neuropharmacology; 1982 Oct; 21(10):953-61. PubMed ID: 6890636 [TBL] [Abstract][Full Text] [Related]
3. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors. Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445 [TBL] [Abstract][Full Text] [Related]
4. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat. Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL Neuropharmacology; 1985 May; 24(5):391-9. PubMed ID: 4022264 [TBL] [Abstract][Full Text] [Related]
5. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279 [TBL] [Abstract][Full Text] [Related]
6. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
7. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat. Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710 [TBL] [Abstract][Full Text] [Related]
8. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents. Campbell A; Yeghiayan S; Baldessarini RJ; Neumeyer JL Psychopharmacology (Berl); 1991; 103(3):323-9. PubMed ID: 1676180 [TBL] [Abstract][Full Text] [Related]
9. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens. Jackson EA; Neumeyer JL; Kelly PH Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639 [TBL] [Abstract][Full Text] [Related]
10. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Kula NS; Baldessarini RJ; Bromley S; Neumeyer JL Life Sci; 1985 Sep; 37(11):1051-7. PubMed ID: 4033350 [TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma. Lampen P; Neumeyer JL; Baldessarini RJ J Chromatogr; 1988 Apr; 426(2):283-94. PubMed ID: 3392141 [TBL] [Abstract][Full Text] [Related]
12. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147 [TBL] [Abstract][Full Text] [Related]
13. The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine. Costall B; Domeney AM; Naylor RJ Neuropharmacology; 1985 Mar; 24(3):193-7. PubMed ID: 3990920 [TBL] [Abstract][Full Text] [Related]
15. Analysis of N-n-propylnorapomorphine in plasma and tissue by capillary gas chromatography--electron-capture detection. Maksoud HM; Kuttab SH; Neumeyer JL; Vouros P J Chromatogr; 1983 May; 274():149-59. PubMed ID: 6874818 [TBL] [Abstract][Full Text] [Related]
16. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines. Costall B; Naylor RJ J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776 [TBL] [Abstract][Full Text] [Related]
17. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine. Campbell A; Baldessarini RJ; Neumeyer JL Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974 [TBL] [Abstract][Full Text] [Related]
18. Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets. Lincoln L; Fisher R; Jackson MJ; Jenner P; Neumeyer J; Sromek AW; Lees AJ; Rose S Mov Disord; 2016 Sep; 31(9):1381-8. PubMed ID: 27133947 [TBL] [Abstract][Full Text] [Related]
19. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons. Cox RF; Neumeyer JL; Waszczak BL J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine. Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]